Amdocs Loses Nearly Half Its Value Overnight — Can an AT&T Deal and a New Acquisition Offset the T-Mobile Crater?

Shares of Amdocs plummeted 43.3% to $35.40 in after-hours trading on November 3, erasing roughly $4 billion in market capitalization after the company projected fiscal 2027 revenue would fall 14.3% to 17.9% year over year. For a stock that had traded in a narrow $62–$64 band for the prior week, the collapse signals that investors were caught completely off guard by the depth of the shortfall. Amdocs Craters 43% After Shocking Revenue Warning — Is the T-Mobile Breakup a Fixable Problem or a Permanent Scar?

Shares of Amdocs collapsed 43.3% to $35.40 after the telecom software provider issued fiscal 2027 guidance calling for a 14.3%–17.9% revenue decline — a gut-punch reversal for a company that just posted $4.70 billion in fiscal 2026 sales, up 3.6% year over year. The overnight implosion erased roughly half the company's market value and laid bare the dangers of extreme customer concentration in an industry where contracts can evaporate with a single dispute.

• T-Mobile Went from Partner to Adversary Almost Overnight. Amdocs and T-Mobile have both issued notices asserting that the other party has materially breached one or more agreements.

Both sides threaten to terminate agreements and pursue monetary and other relief, including in arbitration.

T-Mobile accounted for 19.9% and 22.6% of Amdocs' revenue in fiscal years 2025 and 2024, respectively — meaning a full termination could vaporize close to $1 billion in annual sales. Management cited "major headwinds from T-Mobile due to a recent dispute, the completion of the integration project of the USCellular customers and reduction in T-Mobile's discretionary spending."

• The Revenue Hole Is Staggeringly Wide. Fiscal 2027 guidance projects reported revenue declining 14.3%–17.9%, with non-GAAP earnings per share falling 26%–30%. Applied to the $4.70 billion fiscal 2026 base, that implies roughly $660–$840 million disappearing from the top line in a single year. Even on a constant-currency, pro forma basis the decline is 7%–11%, confirming this is not an accounting footnote but a real shrinkage in billable work.

• An AT&T Deal and Insurance Bet Won't Fill the Gap Quickly. Amdocs announced an eight-year strategic agreement with AT&T — already its largest customer at ~26% of revenue — to modernize operations. It also acquired EIS, a global insurance technology provider, for approximately $340 million in cash , marking its first foray beyond telecom. Both are long-term plays; neither generates the near-term revenue needed to replace T-Mobile's contribution. Insurance is an unproven vertical for Amdocs, and AT&T spending is already mature.

• Customer Concentration Risk Just Became Real. AT&T and T-Mobile together represented roughly 46% of Amdocs' revenue in fiscal 2025.

The top ten clients accounted for approximately 70% of total revenue. Losing one leg of a two-legged stool doesn't just hurt margins — it forces investors to reprice the entire business model's durability. At $35.40, the stock now trades at roughly 5× forward earnings, a distressed-level valuation that reflects genuine uncertainty over whether Amdocs can stabilize before fiscal 2028.